Craneware plc engages in the development, licensing, and ongoing support of computer software for the United States healthcare industry. The company offers patient engagement solutions that enhance patient satisfaction with billing by providing accurate out-of-pocket estimates and mobile-friendly payment plans; reduce bad debt and ineffective paper collections with upfront patient engagement and point-of-service collections; and provide all-payor medical necessity validation and prior authorization coverage to ensure accuracy and prevent denials. It also provides charge capture and pricing solutions, which automate the management of charge and claims data to deliver financial improvement to the provider systems; Trisus Claims Informatics, a retrospective charge capture analytical tool, which identifies high-impact areas of risk for team to investigate; revenue recovery and retention solutions that help in managing denials, underpayments, pre-payments, and retrospective claim audits; and automated cost analytics solutions that enhance financial and operational performance for healthcare organizations. In addition, the company offers professional services, such as customer success manager, revenue cycle assessment, revenue integrity package, custom consulting, CDM review, CDM process designing, chargemaster corporate standardization; and pricing analysis review, on-site training, and charge capture performance services. Further, it provides outsourcing services, including outsourcing CDM management, appeal, and chart-to-bill audits services. The company was founded in 1999 and is headquartered in Edinburgh, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolLON:CRW
Previous Symbol
CUSIPN/A
Phone+44-131-5503100
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees320
Outstanding SharesN/A
Market Cap£0.00
OptionableNot Optionable
Craneware (LON:CRW) Frequently Asked Questions
What is Craneware's stock symbol?
Craneware trades on the London Stock Exchange (LON) under the ticker symbol "CRW."
How often does Craneware pay dividends? What is the dividend yield for Craneware?
Craneware announced a dividend on Tuesday, September 4th. Investors of record on Thursday, November 8th will be given a dividend of GBX 14 per share on Thursday, December 6th. This represents a dividend yield of 0.52%. The ex-dividend date is Thursday, November 8th. This is a positive change from Craneware's previous dividend of $10.00. The official announcement can be accessed at this link. View Craneware's Dividend History.
What price target have analysts set for CRW?
2 brokerages have issued 12 month price targets for Craneware's stock. Their predictions range from GBX 2,800 to GBX 3,600. On average, they expect Craneware's stock price to reach GBX 3,200 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View Analyst Price Targets for Craneware.
What is the consensus analysts' recommendation for Craneware?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Craneware in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Craneware.
Has Craneware been receiving favorable news coverage?
Press coverage about CRW stock has trended positive recently, according to InfoTrie Sentiment. The research firm identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Craneware earned a media sentiment score of 2.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the company's share price in the near future.
Who are some of Craneware's key competitors?
Some companies that are related to Craneware include Alcidion Group (ALC), CardioComm Solutions (EKG), CogState (CGS), Compugroup Medical (COP), Diagnos (ADK), Evitrade Health Systems (AXHLF), eWELLNESS HEALTHCARE (EWLL), Kneat.com (KSI), Novita Healthcare (NHL), OptimizeRx (OPRX), Reliq Health Technologies (RHT), Robertson Global Health Solutions (RHSC), Sensyne Health (SENS), Vitalhub (VHI) and ZoomMed (ZMD).
Who are Craneware's key executives?
Craneware's management team includes the folowing people:
- Mr. Keith Neilson, Co-Founder, CEO & Exec. Director (Age 49)
- Mr. Craig Thomas Preston, CFO, Company Sec. & Exec. Director (Age 47)
- Mr. Marty Smith, Chief Technology Officer
- Mr. Derek W. Paterson, Chief Information Officer
- Seth Droe, Exec. VP of Sales
How do I buy shares of Craneware?
Shares of CRW and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Craneware's stock price today?
One share of CRW stock can currently be purchased for approximately GBX 2,560.
What is Craneware's official website?
How can I contact Craneware?
Craneware's mailing address is 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom. The company can be reached via phone at +44-131-5503100.
MarketBeat Community Rating for Craneware (LON CRW)
MarketBeat's community ratings are surveys of what our community members think about Craneware and other stocks. Vote "Outperform" if you believe CRW will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRW will underperform the S&P 500 over the long term. You may vote once every thirty days.
